Lack of correlation between the 257C-to-T mutation in the gyrA gene and clinical severity of Campylobacter jejuni infection in a region of high incidence of ciprofloxacin resistance

Scandinavian Journal of Infectious Diseases

Volumn 43, Issue 11-12, 2011, Pages 905-911

  Sonnevend, Agnes ^a   Kovacs, Judit ^b   Pal, Tibor ^a   Akawi, Nadia ^a   Nagelkerke, Nico ^a   Schneider, György ^b,c  

^a UNITED ARAB EMIRATES UNIVERSITY   (United Arab Emirates)

^b UNIVERSITY OF PÉCS   (Hungary)

^c INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

Author keywords

Campylobacter jejuni; Ciprofloxacin resistance; Fitness

Indexed keywords

CIPROFLOXACIN; ERYTHROMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL MUTATION; BACTERIAL STRAIN; BACTERIUM ISOLATION; BLOODY DIARRHEA; CAMPYLOBACTER ENTERITIS; CHILD; DIARRHEA; DISEASE PREDISPOSITION; FEMALE; GENETIC HETEROGENEITY; HEMATOCHEZIA; HOSPITALIZATION; HUMAN; HUNGARY; INFANT; MAJOR CLINICAL STUDY; MALE; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CHILD; CHILD, PRESCHOOL; CIPROFLOXACIN; DNA GYRASE; DRUG RESISTANCE, BACTERIAL; ERYTHROMYCIN; FEMALE; GASTROINTESTINAL HEMORRHAGE; HOSPITALIZATION; HUMANS; HUNGARY; INCIDENCE; INFANT; INFANT, NEWBORN; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; POINT MUTATION; YOUNG ADULT;

EID: 80755171268     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2011.603743     Document Type: Article

References (28)

1. Butzler JP. Campylobacter, from obscurity to celebrity. Clin Microbiol Infect 2004;10:868-76.
2. Luo N, Pereira S, Sahin O, Lin J, Huang S, Michel L, et al. Enhanced in vivo fi tness of fl uoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure. Proc Natl Acad Sci U S A 2005;102:541-6. (Pubitemid 40282701)
3. Piddock LJ, Ricci V, Pumbwe L, Everett MJ, Griggs DJ. Fluoroquinolone resistance in Campylobacter species from man and animals: detection of mutations in topoisomerase genes. J Antimicrob Chemother 2003;51:19-26. (Pubitemid 36163823)
4. Zirnstein G, Li Y, Swaminathan B, Angulo F. Ciprofl oxacin resistance in Campylobacter jejuni isolates: detection of gyrA resistance mutations by mismatch amplifi cation mutation assay PCR and DNA sequence analysis. J Clin Microbiol 1999;37:3276 - 80.
5. Albert MJ, Neil L, Pazhoor AA, Haridas S, Rotimi VO, Khan I. Ciprofl oxacin resistance and its molecular mechanism in Campylobacter spp. isolated in Kuwait. Microb Drug Resist 2005;11:266-70. (Pubitemid 41434172)
6. Sonnevend A, Rotimi VO, Kolodziejek J, Usmani A, Nowotny N, Pal T. High level of ciprofl oxacin resistance and its molecular background among Campylobacter jejuni strains isolated in the United Arab Emirates. J Med Microbiol 2006;55(Pt 11):1533-8. (Pubitemid 44713869)
7. Bakeli G, Sato K, Kumita W, Saito R, Ono E, Chida T, et al. Antimicrobial susceptibility and mechanism of quinolone resistance in Campylobacter jejuni strains isolated from diarrheal patients in a hospital in Tokyo. J Infect Chemother 2008;14:342-8.
8. Engberg J, Neimann J, Nielsen EM, Aerestrup FM, Fussing V. Quinolone-resistant Campylobacter infections: risk factors and clinical consequences. Emerg Infect Dis 2004;10: 1056-63. (Pubitemid 38697698)
9. Nelson JM, Smith KE, Vugia DJ, Rabatsky-Ehr T, Segler SD, Kassenborg HD, et al. Prolonged diarrhea due to ciprofl oxacin-resistant Campylobacter infection. J Infect Dis 2004;190:1150-7. (Pubitemid 39186803)
10. Helms M, Simonsen J, Olsen KE, Molbak K. Adverse health events associated with antimicrobial drug resistance in Campylobacter species: A registry-based cohort study. J Infect Dis 2005;191:1050-5. (Pubitemid 40404362)
11. Feodoroff FB, Lauhio AR, Sarna SJ, Hanninen ML, Rautelin HI. Severe diarrhoea caused by highly ciprofl oxacinsusceptible Campylobacter isolates. Clin Microbiol Infect 2009;15:188-92.
12. Wassenaar TM, Kist M, de Jong A. Re-analysis of the risks attributed to ciprofl oxacin-resistant Campylobacter jejuni infections. Int J Antimicrob Agents 2007;30:195-201. (Pubitemid 47126810)
13. Varga J, Fodor L. Biochemical characteristics, serogroup distribution, antibiotic susceptibility and age-related signifi - cance of Campylobacter strains causing diarrhoea in humans in Hungary. Zentralbl Bakteriol 1998;288:67-73. (Pubitemid 28378589)
14. Sonnevend A, Pal T. Heterogeneity of non-serotypable Campylobacter jejuni isolates. Acta Microbiol Immunol Hung 2006;53:171-81. (Pubitemid 44144870)
15. Epidemiological data of Hungary, 2006. EpiInfo 2007;14: 309-26.
16. Clinical and Laboratory Standards Institute. Methods for antimicrobial dilution and disc susceptibility testing of infrequently isolated or fastidious bacteria: Approved guideline. CLSI document M45-A. Wayne, PA: CLSI; 2006.
17. Ayling RD, Woodward MJ, Evans S, Newell DG. Restriction fragment length polymorphism of polymerase chain reaction products applied to the differentiation of poultry campylobacters for epidemiological investigations. Res Vet Sci 1996; 60:168-72. (Pubitemid 126495185)
18. Tamura K, Dudley J, Nei M, Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007;24:1596-9. (Pubitemid 47236692)
19. The " Campynet" PFGE Subtyping Subgroup. " Campynet " prototype standardized protocol for pulse-fi eld gel electrophoresis-based DNA typing of Campylobacter jejuni and Campylobacter coli. Copenhagen; 2000. Available at: http://campynet.vetinst.dk/PFGE.html.
20. Hardin J, Hilbe J. Exchangeable correlation. In: Hardin J, Hilbe J, editors. Generalized estimating equations. London: Chapman and Hall; 2003. p. 59 - 66.
21. The Campylobacter Sentinel Surveillance Scheme Collaborators. Ciprofl oxacin resistance in Campylobacter jejuni: case - case analysis as a tool for elucidating risks at home and abroad. J Antimicrob Chemother 2002; 50:561-8.
22. Unicomb LE, Ferguson J, Stafford RJ, Ashbolt R, Kirk MD, Becker NG, et al. Low-level fl uoroquinolone resistance among Campylobacter jejuni isolates in Australia. Clin Infect Dis 2006;42:1368-74.
23. Payot S, Cloeckaert A, Chaslus-Dancla E. Selection and characterization of fl uoroquinolone-resistant mutants of Campylobacter jejuni using enrofl oxacin. Microb Drug Resist 2002; 8:335-43. (Pubitemid 36043700)
24. Helms M, Simonsen J, Molbak K. Foodborne bacterial infection and hospitalization: A registry-based study. Clin Infect Dis 2006;42:498-506. (Pubitemid 43202522)
25. Gillespie IA, O' B rien SJ, Frost JA, Tam C, Tompkins D, Neal KR, et al. Investigating vomiting and/or bloody diarrhea in Campylobacter jejuni infection. J Med Microbiol 2006;55(Pt 6):741-6. (Pubitemid 43855663)
26. Mead PS, Slutsker L, Dietz V, McCaig LF, Bresee JS, Shapiro C, et al. Food-related illness and death in the United States. Emerg Infect Dis 1999;5:607-25. (Pubitemid 29493763)
27. Wheeler JG, Sethi D, Cowden JM, Wall PG, Rodrigues LC, Tompkins DS, et al. Study of infectious intestinal disease in England: rates in the community, presenting to general practice, and reported to national surveillance. The Infectious Intestinal Disease Study Executive. BMJ 1999;318:1046-50. (Pubitemid 29191897)
28. de Wit MA, Kortbeek LM, Koopmans MP, de Jager CJ, Wannet WJ, Bartelds AI, et al. A comparison of gastroenteritis in a general practice-based study and a communitybased study. Epidemiol Infect 2001;127:389-97. (Pubitemid 34092784)